Aptasensors as a new sensing technology developed for the detection of MUC1 mucin: A review.
Aptamer
Aptasensor
Biosensor
Cancer biomarker
MUC1
Mucin
Journal
Biosensors & bioelectronics
ISSN: 1873-4235
Titre abrégé: Biosens Bioelectron
Pays: England
ID NLM: 9001289
Informations de publication
Date de publication:
01 Apr 2019
01 Apr 2019
Historique:
received:
07
10
2018
revised:
31
12
2018
accepted:
04
01
2019
pubmed:
5
2
2019
medline:
8
6
2019
entrez:
5
2
2019
Statut:
ppublish
Résumé
Mucin 1 protein (MUC1) is a membrane-associated glycoprotein overexpressed in the majority of human malignancies and considered as a predominant protein biomarker in cancers. Owing to the crucial role of MUC1 in cancer dissemination and metastasis, detection and quantification of this biomarker is of great importance in clinical diagnostics. Today, there exist a wide variety of strategies for the determination of various types of disease biomarkers, especially MUC1. In this regard, aptamers, as artificial single-stranded DNA or RNA oligonucleotides with catalytic and receptor properties, have drawn lots of attention for the development of biosensing platforms. So far, various sensitivity-enhancement techniques in combination with a broad range of smart nanomaterials have integrated into the design of novel aptamer-based biosensors (aptasensors) to improve detection limit and sensitivity of analyte determination. This review article provides a brief classification and description of the research progresses of aptamer-based biosensors and nanobiosensors for the detection and quantitative determination of MUC1 based on optical and electrochemical platforms.
Identifiants
pubmed: 30716589
pii: S0956-5663(19)30038-7
doi: 10.1016/j.bios.2019.01.015
pii:
doi:
Substances chimiques
Aptamers, Nucleotide
0
DNA, Single-Stranded
0
MUC1 protein, human
0
Mucin-1
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
1-19Informations de copyright
Copyright © 2019 Elsevier B.V. All rights reserved.